365. Neurocognitive Function Change after Switching from Efavirenz to Rilpivirine in HIV-Infected Adults: A Randomized Control Trial

BACKGROUND: HIV-associated neurocognitive disorders (HAND) remain problematic even in the antiretroviral therapy (ART) era. Efavirenz (EFV) is well known for neuropsychiatric side effects and has been associated with worsening neurocognitive performance (NC). We hypothesized that switching from an A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewpoowat, Quanhathai, Thongton, Wirongrong, Robertson, Kevin, Chaiwarith, Romanee, Robbins, Nathaniel, Supparatpinyo, Khuanchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809805/
http://dx.doi.org/10.1093/ofid/ofz360.438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809805/
http://dx.doi.org/10.1093/ofid/ofz360.438

Ejemplares similares